Related Experiment Video

Updated: Nov 26, 2025

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.8K

Aging-related modifications to G protein-coupled receptor signaling diversity

Jaana van Gastel1, Hanne Leysen1, Jan Boddaert2

  • 1Receptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium; Faculty of Pharmacy, Biomedical and Veterinary Science, University of Antwerp, Antwerp, Belgium.

Pharmacology & Therapeutics
|December 14, 2020
PubMed

Insights

This review explores G protein-coupled receptors (GPCRs) as potential anti-aging drug targets. By understanding biased ligand signaling, researchers can develop precision medicines to combat aging and related diseases.

Area of Science:

  • Molecular biology
  • Pharmacology
  • Gerontology

Background:

  • Aging is a complex molecular process and the primary risk factor for neurodegenerative, cardiovascular, and metabolic diseases.
  • Current therapeutics primarily target G protein-coupled receptors (GPCRs), highlighting their importance in drug development.
  • The need for more specific drugs to attenuate or reverse aging features drives research into novel therapeutic strategies.

Purpose of the Study:

  • To explore the potential of GPCRs and their signaling diversity as targets for anti-aging therapeutics.
  • To investigate biased ligand signaling profiles for developing selective therapeutics.
  • To identify novel effector profiles for precision medicine in aging and age-related disorders.

Main Methods:

  • Review of existing literature on GPCR signaling and aging.
  • Analysis of biased ligand signaling profiles using molecular biology techniques.
  • High-dimensionality data analyses to understand signaling bias.

Main Results:

  • GPCRs represent a promising domain for discovering anti-aging therapeutics.
  • Understanding GPCR signaling diversity, including biased signaling, is key to developing selective drugs.
  • Novel effector profiles can be identified through nuanced analysis of signaling bias.

Conclusions:

  • Targeting GPCRs, particularly through biased ligand signaling, offers a pathway to develop effective anti-aging drugs.
  • Precision medicine approaches can be advanced by identifying novel GPCR effector profiles.
  • Further research into non-G protein GPCR effectors holds therapeutic potential for aging and age-related diseases.
Keywords:
GPCRage-related disordersbiasnon-G protein-dependent signaling

More Related Videos

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.4K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.2K

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.3K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.3K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
9.2K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.5K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
3.3K